Navigation Links
BMP Sunstone Appoints Daniel Harrington to Board of Directors
Date:10/28/2009

PLYMOUTH MEETING, PA., Oct. 28 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP) ("BMP Sunstone" or the "Company"), today announced the appointment of Daniel P. Harrington to the Company's Board of Directors.

Mr. Harrington brings more than thirty years of management experience to BMP Sunstone, including extensive experience working with publicly traded companies. Since 1995, he has been President and CEO of HTV Industries, a diversified holding company with interests in manufacturing, distribution and banking. Mr. Harrington is a CPA and began his career at Arthur Andersen & Co. Mr. Harrington is a Board Director of Churchill Downs (NASDAQ: CHDN) and Portec Rail Products, Inc. (NASDAQ: PRPX).

Mr. David Gao, Chief Executive Officer of BMP Sunstone, said, "On behalf of the Board of Directors and management, I am delighted to welcome Mr. Harrington to BMP Sunstone. We look forward to his contributions to BMP Sunstone's growth given his strong leadership capabilities, experience as a director and extensive financial accounting and reporting experience."

Mr. Harrington has a B.B.A. in Accounting from Stetson University and an M.B.A. from Xavier University. He also serves on the Board of Trustees of Case Western Reserve University and the Veale Foundation.

About BMP Sunstone Corporation

BMP Sunstone Corporation is a specialty pharmaceutical company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China. Through Sunstone Pharmaceutical Co. Ltd., the Company manufactures leading pediatric and women's health products, including two of China's most recognized brands, "Hao Wawa" and "Confort," sold throughout the country in approximately 120,000 pharmacies. The Company also markets a portfolio of products under exclusive multi-year licenses into China, primarily focused on women's health and pediatrics, as well as provides pharmaceutical distribution services through subsidiaries in Beijing and Shanghai. BMP Sunstone's main office is in Beijing, with a U.S. office in Plymouth Meeting, PA. For more information, please visit http://www.bmpsunstone.com .

    For more information, please contact:

     Integrated Corporate Relations, Inc.
     Ashley M. Ammon and Christine Duan
     Tel: +1-203-682-8200 (Investor Relations)

SOURCE BMP Sunstone Corporation


'/>"/>
SOURCE BMP Sunstone Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results
2. BMP Sunstone to Present at UBS Global Healthcare Services Conference
3. BMP Sunstone Adopts Voluntary Executive Compensation Restrictions in 2008 and 2009
4. BMP Sunstone Receives High Tech Status
5. BMP Sunstone to Present at the 20th Annual Piper Jaffray Health Care Conference
6. BMP Sunstone Acquires Runchang Capsule and Related LFHC Technology
7. BMP Sunstone to Host Follow-Up 3Q08 Conference Call Due to Technical Difficulties Encountered on Tuesdays Call
8. BMP Sunstone Reports Third Quarter 2008 Financial Results
9. BMP Sunstone Announces Participation in November Investor Conferences
10. BMP Sunstone Announces Participation in September Investor Conference
11. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... 28, 2017 Sangamo Therapeutics, Inc. (NASDAQ: ... reported its fourth quarter and full year 2016 ... this year we rebranded our company as Sangamo ... genomic therapies using our industry leading platform technologies ... cell therapy," said Sandy Macrae , CEO ...
(Date:2/28/2017)... , February 28, 2017 The ... for assessment are the following equities: ZIOPHARM Oncology Inc. (NASDAQ: ... AUPH ), Arena Pharmaceuticals Inc. (NASDAQ: ARNA ), ... companies belong to the Healthcare sector, which was narrowly mixed ... Health Care Index declining less than 0.1%, while shares of ...
(Date:2/27/2017)... , February 27, 2017 A Europe-wide ... indicated that researchers using animals in their research treat them with ... 26 countries, and detailed analysis of the results indicates that there ... to put into practice the principles of the 3Rs ... ...
(Date:2/27/2017)... CITY, Calif. , Feb. 27, 2017 /PRNewswire/ ... pharmaceutical company focused on the development and commercialization ... acute pain, announced today the U.S. Food and ... Drug Application (NDA) under section 505(b)(2) for DSUVIA™ ... the treatment of patients with moderate-to-severe acute pain ...
Breaking Biology Technology:
(Date:2/7/2017)... 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... will present at the LEERINK Partners 6th Annual Global ... on Wednesday, February 15, 2017 at 10 a.m. Eastern ... presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  The ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:2/6/2017)... , Feb. 6, 2017 According to ... are driving border authorities to continue to embrace ... there are 2143 Automated Border Control (ABC) eGates ... deployed at more than 163 ports of entry ... to 2016 achieving a combined CAGR of 37%. ...
(Date:2/3/2017)... -- A new independent identity strategy consultancy firm announces ... Designed to fill a critical niche in technical and ... Mark Crego and Janice Kephart ... expertise that span federal governments, the 9/11 Commission, private ... expertise has a common theme born from a shared ...
Breaking Biology News(10 mins):